AccuStem Sciences, Inc. is a clinical stage diagnostics company, which engages in medical practice activities. The company is headquartered in New York City, New York and currently employs 2 full-time employees. The company went IPO on 2022-03-01. The company is focused on developing and commercializing a suite of genomic tests that support decision-making along the entire continuum of oncology care. The company focuses on its proprietary genomic tests, MicroRNA Signature Classifier (MSC) for patients with lung nodules and StemPrintER for patients with early-stage breast cancer. The MSC test, a 24-micro-RNA (miRNA) assay designed to help determine whether lung nodules identified by low-dose computer tomography (LDCT) screening, are benign or malignant. StemPrintER, a 20-gene prognostic assay intended to predict the risk of distant recurrence (DR) in luminal (ER+/HER2-negative) breast cancer patients. The assay is developed to measure the stemness of tumors, or how much a tumor behaves like stem cells, which could indicate how likely a cancer is to recur or be resistant to standard treatments, ultimately impacting how patients are managed by their multidisciplinary care team.
ACUT stock price ended at $0.6 on Lundi, after dropping 4.76%
On the latest trading day Jan 26, 2026, the stock price of ACUT fell by 4.76%, dropping from $0.60 to $0.60. During the session, the stock saw a volatility of 0.00%, with prices oscillating between a daily low of $0.60 and a high of $0.60. On the latest trading day, the trading volume for ACUT decreased by 1.1K shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, 173 shares were traded, with a market value of approximately $9.6M.
Signaux Techniques de ACUT
Résumé des Signaux Techniques
Acheter des signaux 2
Signaux neutres 1
Signaux de vente 4
Strong Sell
Sell
Neutral
Buy
Strong Buy
ACUT présente actuellement 2 signaux d'achat et 4 signaux de vente. L'action est en Tendance baissière depuis 12:00 AM, avec une variation totale du prix de -7.69% pendant cette période. En général, les indicateurs techniques indiquent une tendance Sell à moyen terme.
Signaux haussiers/baissiers pour ACUT
Nous analysons les indicateurs clés comme les moyennes mobiles, le RSI, le MACD et le volume de transactions pour générer des signaux haussiers et baissiers pour ACUT, vous aidant à prendre des décisions d'investissement éclairées.
Questions complémentaires
Comment les indicateurs d'analyse technique s'appliquent-ils à ACUT ?
Quels sont les niveaux de retracement de Fibonacci pour ACUT ?
Quel est le RSI de Accustem Sciences Inc ?
Quel est le prix de Accustem Sciences Inc pour les 12 prochains mois ?